Skip to Content
You are currently on the new version of our website. Access the old version .
BiomoleculesBiomolecules
  • Review
  • Open Access

14 November 2026

66 Pages

Madecassoside Part I: From Biosynthesis to Druggability

,
,
,
,
,
and
1
Research Center of Trace Elements and Health Development, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China
2
School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China
3
School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China
4
Guiyang Institute of Information Science and Technology, Guiyang 550025, China
Biomolecules2026, 16(11), 1663;https://doi.org/10.3390/biom16111663 
(registering DOI)
This article belongs to the Special Issue Advances in Pharmacognosy and Phytochemistry: From Molecular to Pre-Clinical Insights

Abstract

Background: Madecassoside (MA) is the core bioactive pentacyclic triterpenoid saponin and a key quality control marker of Centella asiatica (L.) Urb. Its material basis and druggability profiles are fundamental prerequisites for pharmacological research and clinical translation. Although several reviews have covered selected aspects of MA chemistry and pharmacology, no systematic review has comprehensively covered the full chain from chemical structure to in vivo disposition exclusively for MA monomer. Objective: As the first part of a two-part series, this review aims to systematically integrate evidence on the chemical basis, biosynthesis, green preparation, and pharmacokinetic characteristics of MA and clarify the core druggability bottlenecks of this compound. Methods: The literature search was conducted in PubMed, Web of Science, and China National Knowledge Infrastructure (CNKI) up to 31 August 2026. Studies focusing on the chemistry, biosynthesis, extraction/purification, and pharmacokinetics of MA were included and critically analyzed. Evidence was stratified into four predefined levels: Level A (clinical trials), Level B (in vivo animal studies), Level C (in vitro cell/molecular studies), Level D (computational prediction). The limitation of Chinese literature to Peking University core journals is acknowledged as a potential source of publication bias. Results: Current evidence supports that the C-6 β-hydroxyl group on the ursane-type aglycone skeleton and the intact linear trisaccharide chain at the C-28 position are the major structural correlates of MA’s biological activity (working hypothesis based on natural analog comparisons). The backbone cyclization and glycosylation steps in the MA biosynthetic pathway have been largely characterized, but the specific enzymes responsible for C-2 α- and C-6 β-hydroxylation remain to be fully identified. Green extraction technologies such as ultrasound-assisted extraction, microwave-assisted extraction, and deep eutectic solvent extraction have been well optimized, and multiple purification strategies can yield high-purity monomers. In rats, the oral absolute bioavailability of the pure MA prototype is less than 1%, with extensive intestinal metabolism and enterohepatic circulation, representing the core druggability bottleneck. Human pharmacokinetic data remain very limited, and rat values cannot be directly extrapolated to humans. Conclusions: This review establishes a full-chain material basis framework for madecassoside spanning from molecular structure to in vivo disposition, systematically integrating evidence on structural activity determinants, biosynthetic pathways, green extraction and purification technologies, and pharmacokinetic profiles. Extremely low oral bioavailability and extensive in vivo metabolic transformation are confirmed as the core druggability bottlenecks. These findings lay the essential foundation for elucidating pharmacological mechanisms, optimizing delivery systems, and advancing clinical translation in the second part of this series. To our knowledge, this is the first two-part systematic review focused exclusively on the MA monomer that covers the full translational spectrum from chemical fundamentals and druggability profiles to pharmacological mechanisms and clinical translation.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.